Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2019

Open Access 01-12-2019 | Lung Cancer | Research article

LncRNA LUADT1 sponges miR-15a-3p to upregulate Twist1 in small cell lung cancer

Authors: Dingxue Wang, Wenyu Wu, Wenqi Huang, Jinghui Wang, Li Luo, Dongxin Tang

Published in: BMC Pulmonary Medicine | Issue 1/2019

Login to get access

Abstract

Lung adenocarcinoma associated transcript 1 (LUADT1) has been reported as an oncogenic long non-coding RNA (lncRNA) in lung adenocarcinoma, while its roles in small cell lung cancer (SCLC) are unknown. Our RNA interaction bioinformatics prediction showed that LUADT1 could form strong base pairing with miR-15a-3p, which is a tumor-suppressive miRNA that can target Twist1. We found that LUADT1 and Twist1 were upregulated in SCLC, while miR-15a-3p was downregulated in SCLC. However, LUADT1 was posively correlated with Twist1 but was not significnatly correlated with miR-15a-3p. Overexpression experiments showed that and LUADT1 and miR-15a-3p did not significantly affect the expression of each other. Moreover, LUADT1 overexpression mediated the upregualtion of Twist1, and miR-15a-3p overexpression played an oppsoite role. Transwell assays showed that LUADT1 and Twist1 overexpression mediated the increased rate of cell invasion and migration, while miR-15a-3p overexpression mediated the decreased rate of cell invasion and migration. In addition, miR-15a-3p overexpression played an oppsoite role and attenuated the effects of LUADT1 overexpression. Therefore, LUADT1 may sponge miR-15a-3p to upregulate Twist1 in SCLC, thereby promoting cancer cell invasion and migration.

Trial registration

2017GZH-1-201,746,382, registered at Jan 02,2017.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin. 2018;68(6):394–424. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin. 2018;68(6):394–424.
2.
go back to reference Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods[J]. Int J Cancer. 2019;144(8):1941–53.CrossRef Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods[J]. Int J Cancer. 2019;144(8):1941–53.CrossRef
3.
go back to reference Byers LA, Rudin CM. Small cell lung cancer: where do we go from here?[J]. Cancer. 2015;121(5):664–72.CrossRef Byers LA, Rudin CM. Small cell lung cancer: where do we go from here?[J]. Cancer. 2015;121(5):664–72.CrossRef
4.
go back to reference Kaur G, Reinhart RA, Monks A, et al. Bromodomain and hedgehog pathway targets in small cell lung cancer[J]. Cancer Lett. 2016;371(2):225–39.CrossRef Kaur G, Reinhart RA, Monks A, et al. Bromodomain and hedgehog pathway targets in small cell lung cancer[J]. Cancer Lett. 2016;371(2):225–39.CrossRef
5.
go back to reference Gazdar AF, Bunn PA, Minna JD. Small-cell lung cancer: what we know, what we need to know and the path forward[J]. Nat Rev Cancer. 2017;17(12):725–37.CrossRef Gazdar AF, Bunn PA, Minna JD. Small-cell lung cancer: what we know, what we need to know and the path forward[J]. Nat Rev Cancer. 2017;17(12):725–37.CrossRef
6.
go back to reference Niu Y, Ma F, Huang W, et al. Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2[J]. Mol Cancer. 2017;16(1):5.CrossRef Niu Y, Ma F, Huang W, et al. Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2[J]. Mol Cancer. 2017;16(1):5.CrossRef
7.
go back to reference Sun Y, Hu B, Wang Q, et al. Long non-coding RNA HOTTIP promotes BCL-2 expression and induces chemoresistance in small cell lung cancer by sponging miR-216a[J]. Cell Death Dis. 2018;9(2):85.CrossRef Sun Y, Hu B, Wang Q, et al. Long non-coding RNA HOTTIP promotes BCL-2 expression and induces chemoresistance in small cell lung cancer by sponging miR-216a[J]. Cell Death Dis. 2018;9(2):85.CrossRef
8.
go back to reference Mizuno K, Mataki H, Arai T, et al. The microRNA expression signature of small cell lung cancer: tumor suppressors of miR-27a-5p and miR-34b-3p and their targeted oncogenes[J]. J Hum Genet. 2017;62(7):671–8.CrossRef Mizuno K, Mataki H, Arai T, et al. The microRNA expression signature of small cell lung cancer: tumor suppressors of miR-27a-5p and miR-34b-3p and their targeted oncogenes[J]. J Hum Genet. 2017;62(7):671–8.CrossRef
9.
go back to reference Esteller M. Non-coding RNAs in human disease[J]. Nat Rev Genet. 2011;12(12):861–74.CrossRef Esteller M. Non-coding RNAs in human disease[J]. Nat Rev Genet. 2011;12(12):861–74.CrossRef
10.
go back to reference Paraskevopoulou MD, Hatzigeorgiou AG. Analyzing miRNA–lncRNA interactions[M]//long non-coding RNAs. New York: Humana Press; 2016. p. 271–86.CrossRef Paraskevopoulou MD, Hatzigeorgiou AG. Analyzing miRNA–lncRNA interactions[M]//long non-coding RNAs. New York: Humana Press; 2016. p. 271–86.CrossRef
11.
go back to reference Qiu M, Xu Y, Wang J, et al. A novel lncRNA, LUADT1, promotes lung adenocarcinoma proliferation via the epigenetic suppression of p27[J]. Cell Death Dis. 2015;6(8):e1858.CrossRef Qiu M, Xu Y, Wang J, et al. A novel lncRNA, LUADT1, promotes lung adenocarcinoma proliferation via the epigenetic suppression of p27[J]. Cell Death Dis. 2015;6(8):e1858.CrossRef
12.
go back to reference Wang T, Hou J, Li Z, et al. miR-15a-3p and miR-16-1-3p negatively regulate Twist1 to repress gastric cancer cell invasion and metastasis[J]. Int J Biol Sci. 2017;13(1):122–34.CrossRef Wang T, Hou J, Li Z, et al. miR-15a-3p and miR-16-1-3p negatively regulate Twist1 to repress gastric cancer cell invasion and metastasis[J]. Int J Biol Sci. 2017;13(1):122–34.CrossRef
13.
go back to reference Shukla V, Mcloughlin K, Gao J, et al. Comparative Transcriptomic analysis of lung-iPSC, NSCLC, and SCLC: potential implications for iPSC modeling of lung Cancer[J]. J Thorac Oncol. 2018;13(10):S912.CrossRef Shukla V, Mcloughlin K, Gao J, et al. Comparative Transcriptomic analysis of lung-iPSC, NSCLC, and SCLC: potential implications for iPSC modeling of lung Cancer[J]. J Thorac Oncol. 2018;13(10):S912.CrossRef
14.
go back to reference Ferrer L, Levra MG, Brevet M, et al. A brief report of transformation from NSCLC to SCLC: molecular and therapeutic characteristics[J]. J Thorac Oncol. 2019;14(1):130–4.CrossRef Ferrer L, Levra MG, Brevet M, et al. A brief report of transformation from NSCLC to SCLC: molecular and therapeutic characteristics[J]. J Thorac Oncol. 2019;14(1):130–4.CrossRef
15.
go back to reference Fan B, Chen LP, Yuan YH, et al. MiR-15a-3p suppresses the growth and metastasis of ovarian cancer cell by targeting Twist1[J]. Eur Rev Med Pharmacol Sci. 2019;23(5):1934–46.PubMed Fan B, Chen LP, Yuan YH, et al. MiR-15a-3p suppresses the growth and metastasis of ovarian cancer cell by targeting Twist1[J]. Eur Rev Med Pharmacol Sci. 2019;23(5):1934–46.PubMed
17.
go back to reference Grither WR, Divine LM, Meller EH, et al. TWIST1 induces expression of discoidin domain receptor 2 to promote ovarian cancer metastasis[J]. Oncogene. 2018;37(13):1714–29.CrossRef Grither WR, Divine LM, Meller EH, et al. TWIST1 induces expression of discoidin domain receptor 2 to promote ovarian cancer metastasis[J]. Oncogene. 2018;37(13):1714–29.CrossRef
18.
go back to reference Saxena M, Balaji SA, Deshpande N, et al. AMP-activated protein kinase promotes epithelial-mesenchymal transition in cancer cells through Twist1 upregulation[J]. J Cell Sci. 2018;131(14):jcs208314.CrossRef Saxena M, Balaji SA, Deshpande N, et al. AMP-activated protein kinase promotes epithelial-mesenchymal transition in cancer cells through Twist1 upregulation[J]. J Cell Sci. 2018;131(14):jcs208314.CrossRef
Metadata
Title
LncRNA LUADT1 sponges miR-15a-3p to upregulate Twist1 in small cell lung cancer
Authors
Dingxue Wang
Wenyu Wu
Wenqi Huang
Jinghui Wang
Li Luo
Dongxin Tang
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2019
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-019-0991-7

Other articles of this Issue 1/2019

BMC Pulmonary Medicine 1/2019 Go to the issue